{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:18:15Z","timestamp":1793596695285,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejso.2023.107035","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:15:04Z","timestamp":1692242104000},"page":"107035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lessons learnt from 1300 consecutive gallbladder cancer surgeries: Evolving role of peri-operative chemotherapy in the treatment paradigm"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-6825","authenticated-orcid":false,"given":"Shraddha","family":"Patkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-3271","authenticated-orcid":false,"given":"Swapnil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0067-4748","authenticated-orcid":false,"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2023.107035_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder Cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.ejso.2023.107035_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12957-020-01915-7","article-title":"Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases","volume":"18","author":"Chang","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2023.107035_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107035_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jso.24837","article-title":"Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center","volume":"117","author":"Patkar","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107035_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46912","article-title":"A\u00a0propensity score analysis of chemotherapy use in patients with resectable gallbladder cancer","volume":"5","author":"Ozer","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2023.107035_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101951","article-title":"Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study","volume":"59","author":"Balakrishnan","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejso.2023.107035_bib7","article-title":"Benchmarks and geographic differences in gallbladder cancer surgery: an International Multicenter study","author":"Vega","year":"2023","journal-title":"Ann Surg Oncol [Internet]"},{"issue":"6","key":"10.1016\/j.ejso.2023.107035_bib8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s11605-022-05290-4","article-title":"High-quality surgery for gallbladder carcinoma: rare, associated with disparity, and not substitutable by chemotherapy","volume":"26","author":"Salehi","year":"2022","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.ejso.2023.107035_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jso.24546","article-title":"Global epidemiological trends and variations in the burden of gallbladder cancer","volume":"115","author":"Are","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107035_bib10","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging: the eighth edition AJCC cancer staging manual","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ejso.2023.107035_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB"},{"issue":"3","key":"10.1016\/j.ejso.2023.107035_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1477-2574.2011.00430.x","article-title":"Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer","volume":"14","author":"Pandey","year":"2012","journal-title":"HPB"},{"issue":"4","key":"10.1016\/j.ejso.2023.107035_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/cco.2019.07.07","article-title":"Achieving margin negative resection\u2014doing less is justified: oncological outcomes of wedge excision of liver in gallbladder cancer (GBC) surgery","volume":"8","author":"Patkar","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107035_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.hpb.2022.12.003","article-title":"Utility and limitations of intraoperative frozen section diagnosis to determine optimal surgical strategy in suspected gallbladder malignancy","volume":"25","author":"Patkar","year":"2023","journal-title":"HPB"},{"issue":"4","key":"10.1016\/j.ejso.2023.107035_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jhbp.712","article-title":"Role of positron emission tomography-contrast enhanced computed tomography in locally advanced gallbladder cancer","volume":"27","author":"Patkar","year":"2020","journal-title":"J\u00a0Hepato-Biliary-Pancreatic Sci"},{"issue":"6","key":"10.1016\/j.ejso.2023.107035_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jso.24198","article-title":"Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma: PET Scan in Incidental Gallbladder Carcinoma","volume":"113","author":"Goel","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2023.107035_bib17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ejso.2022.03.013","article-title":"Node positivity in T1b gallbladder cancer: a high volume centre experience","volume":"48","author":"Goel","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2023.107035_bib18","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1245\/s10434-021-09687-4","article-title":"Revision surgery for incidental gallbladder cancer\u2014challenging the dogma: ideal timing and real-World applicability","volume":"28","author":"Patkar","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107035_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-018-1115-6","article-title":"Gemcitabine\u2013cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward","volume":"35","author":"Ostwal","year":"2018","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107035_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4103\/ijc.IJC_516_17","article-title":"Radiological diagnosis alone risks overtreatment of benign disease in suspected gallbladder cancer: a word of caution in an era of radical surgery","volume":"54","author":"Patkar","year":"2017","journal-title":"Indian J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2023.107035_bib21","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1245\/s10434-021-09702-8","article-title":"ASO author reflections: revision surgery or timely chemotherapy for incidental gallbladder cancers: what is actually helping?","volume":"28","author":"Patkar","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107035_bib22","article-title":"Impact of enhanced recovery pathway in 408 gallbladder cancer resections","author":"Joshi","year":"2021","journal-title":"HPB"},{"issue":"18","key":"10.1016\/j.ejso.2023.107035_bib23","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2023.107035_bib24","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"Swog S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107035_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and Oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2023.107035_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB"},{"issue":"16","key":"10.1016\/j.ejso.2023.107035_bib27","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107035_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2023.107035_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhbp.314","article-title":"Biliary tract cancer registry in Japan from 2008 to 2013","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Hepato-Biliary-Pancreatic Sci"},{"issue":"4","key":"10.1016\/j.ejso.2023.107035_bib30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4143\/crt.2017.279","article-title":"Trends in gallbladder cancer incidence and survival in Korea","volume":"50","author":"Wi","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.ejso.2023.107035_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.ejso.2023.107035_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","volume":"20","author":"Goetze","year":"2020","journal-title":"BMC Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832300673X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832300673X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:48:45Z","timestamp":1760060925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832300673X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S074879832300673X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107035","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learnt from 1300 consecutive gallbladder cancer surgeries: Evolving role of peri-operative chemotherapy in the treatment paradigm","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107035"}}